|
INCENP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.39169999652844E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.10779999909994E-08 |
| Normal-vs-Stage2 |
2.046000E-02 |
| Normal-vs-Stage3 |
1.71830000228468E-08 |
| Normal-vs-Stage4 |
5.34430000254105E-08 |
| Stage1-vs-Stage2 |
4.846400E-02 |
| Stage1-vs-Stage3 |
3.366400E-01 |
| Stage1-vs-Stage4 |
4.685000E-01 |
| Stage2-vs-Stage3 |
2.249600E-02 |
| Stage2-vs-Stage4 |
2.821800E-02 |
| Stage3-vs-Stage4 |
9.961400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41550000054558E-07 |
| Normal-vs-AfricanAmerican |
8.33270000000219E-07 |
| Normal-vs-Asian |
5.15870013373387E-10 |
| Caucasian-vs-AfricanAmerican |
6.927600E-01 |
| Caucasian-vs-Asian |
2.317800E-03 |
| AfricanAmerican-vs-Asian |
8.916500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.33820000034224E-07 |
| Normal-vs-Female |
6.84249999993725E-08 |
| Male-vs-Female |
8.316600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.37709999859359E-08 |
| Normal-vs-Age(41-60Yrs) |
7.21170000383964E-08 |
| Normal-vs-Age(61-80Yrs) |
4.84259999999903E-06 |
| Normal-vs-Age(81-100Yrs) |
1.260370E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.363200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.751200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.009200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.997950E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.949000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.617800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.359400E-03 |
| Classical-VS-Follicular |
4.787600E-02 |
| Classical-VS-Other |
4.430200E-01 |
| Classical-VS-Normal |
1.13959999992197E-07 |
| Tall-VS-Follicular |
1.376400E-04 |
| Tall-VS-Other |
7.850200E-01 |
| Tall-VS-Normal |
5.25789967120716E-10 |
| Follicular-VS-Other |
2.089600E-01 |
| Follicular-VS-Normal |
1.238200E-04 |
| Other-VS-Normal |
1.761620E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.37739999994668E-06 |
| Normal-vs-N1 |
1.96990002088171E-09 |
| N0-vs-N1 |
4.180100E-03 |
|
|
